We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
ReadyGo Diagnostics initiates volume manufacturing of its sample collection and preparation device with Porex. ReadyGo Diagnostics partners with Porex to scale up production of innovative Sampler, with applications
The British In Vitro Diagnostics Association (BIVDA) have released new three-year strategy, ‘Diagnostics for All’. Our ambition remains to represent the core interests of our members to shape
Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced today, ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global), that it
P95, a leading global provider of clinical and epidemiology services focused on vaccines and infectious diseases, has opened its first office in the USA. Based in the Research Triangle
CSafe, an active and passive temperature-controlled shipping solutions provider for the biopharmaceutical industry, proudly announces the launch of a new line of cryogenic multi-use dewars for the cell
On Apr. 11, 2024, VITAL HealthCare, one of the 5 core business divisions of the VITAL Group, marked a stunning debut at the 89th China International Medical Equipment Fair (CMEF)
The 89th edition of the China International Medical Equipment Fair (CMEF) witnessed an impressive turnout of over 200,000 attendees from more than 150 countries. Prominent companies in the industry seized the
Insightec reaffirms its position at the forefront of the medical technology industry with improved functionality, safety features, and efficiency to its flagship product, setting new benchmarks in the
Approval enables regulated analysis services for cell and gene therapies. This important milestone for TATAA Biocenter provides customers access to safety testing, accelerating the transition of promising therapies
Exciting news in the realm of wound care! The Wound Healing Society has recently increased topical oxygen therapy to ‘Level 1’ evidence in its updated DFU treatment guidelines, signifying a significant